Strides Pharma Science executes definitive agreements with ICP-III Investment Advisors

31 Oct 2018 Evaluate

Strides Pharma Science has executed definitive agreements with funds advised by ICP?III Investment Advisors (ICP) to provide growth capital and focused attention to its Consumer Healthcare Business (CHC).

ICP would provide the business with a $20 million capital for growth. The CHC business comprises of key brands including JointFlex, Pediacare, NiteThru and NixIt sold across key regulated and emerging markets. The business had revenues of $6.4 million for FY18.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

808.95 12.75 (1.60%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×